Teva Pharmaceuticals
TEVA
TEVA
429 hedge funds and large institutions have $4.47B invested in Teva Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 134 increasing their positions, 140 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 140
6% less funds holding
Funds holding: 454 → 429 (-25)
30% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 63
Holders
429
Holding in Top 10
12
Calls
$305M
Puts
$314M
Top Buyers
| 1 | +$317M | |
| 2 | +$194M | |
| 3 | +$93M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$38.3M |
| 5 |
Two Sigma Investments
New York
|
+$37.3M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$57.5M | |
| 3 | -$50M | |
| 4 |
GAM
Goldentree Asset Management
New York
|
-$28.7M |
| 5 |
Citigroup
New York
|
-$28M |